🕒 Friday 31 October 2025 Fri, 31 Oct 2025

Western Yilgarn NL has significantly boosted its bauxite portfolio with two new JORC-compliant resource estimates and confirmed high-grade gallium and cobalt discoveries, positioning itself strongly in critical minerals and gold exploration.

Artrya Limited has completed the second tranche of its share placement, raising $14.7 million to advance its AI-powered Salix platform for coronary artery disease detection.

Golden Horse Minerals has raised A$35 million through a strongly supported placement to accelerate exploration and development at its Southern Cross Gold Project in Western Australia.

Central Petroleum reported a slight dip in sales volumes and revenue for the September quarter, offset by a significant reserves upgrade and a new long-term gas supply agreement that promises cash flow stability.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Codeifai Limited reports a 10% revenue increase in Q3 2025 and completes due diligence on the QuantumAI Secure platform acquisition, signaling a strategic pivot into quantum-resilient fintech solutions.

Hawk Resources advances exploration with imminent drilling at five copper-gold targets in Utah and secures an option to acquire a major scandium project in Western Australia, supported by a $5 million placement.

Apollo Minerals reports encouraging exploration results from its Gabon projects, highlighting significant gold intercepts at Salanie and a substantial zinc-lead target at Kroussou, while navigating funding constraints and ongoing legal challenges in Europe.

Midas Minerals has secured unconditional approval from Namibia’s Competition Commission, paving the way to complete its acquisition of the Otavi Copper Project and launch an aggressive drilling campaign.

Cooper Metals is gearing up for drilling at its Mt Isa East copper-gold project while divesting a majority stake in its Gilberton Gold Project to Sybella Metals, maintaining a solid cash position to fund exploration.

Superior Resources has boosted its Greenvale Project area by 56%, revealing exceptional copper-gold-silver assay results and advancing its Steam Engine Gold Project towards production within two years.

PolarX advances its Alaska and Nevada exploration projects with a $5.1 million capital raise and a significant joint venture deal with Northern Star Resources, unlocking up to US$39 million in staged funding.

archTIS has significantly expanded its U.S. footprint through the acquisition of Spirion LLC and a new Department of Defense contract, supported by a A$20.5 million capital raise. These moves position the company for accelerated growth in the lucrative U.S. defense and enterprise cybersecurity markets.

GBM Resources has launched a major drilling campaign at its Twin Hills gold project and raised A$40 million to fund exploration and development across its Drummond Basin portfolio.

Fin Resources Limited has acquired a 100% interest in the drill-ready Cabin Lake Gold Project in Canada’s Northwest Territories, backed by a recent A$1.5 million capital raise to accelerate exploration activities.

Australian Bond Exchange Holdings (ASX – ABE) unveiled new AUD-denominated market-linked securities and progressed its AI-driven credit analysis tool, while reporting a $0.7 million quarterly cash outflow and plans for capital raising.

SRJ Technologies has made significant strides in its three-year growth plan, securing a $6 million joint venture with a Middle East National Oil Company and raising £1.4 million to fund its regional expansion.

Turaco Gold has significantly expanded its Afema Project gold resource to 4.06 million ounces, driven by high-grade discoveries at multiple deposits and a strong financial position supporting ongoing development.

Wide Open Agriculture advances its lupin protein commercialisation with a strategic China rollout, sustainability validation, and plans for a large-scale Australian facility.

Alterity Therapeutics reports strengthened efficacy signals for ATH434 in Multiple System Atrophy and secures a robust cash position to fuel upcoming Phase 3 trials.

AustChina Holdings has made significant progress in its Tasmanian gold and base metals projects while securing an option to acquire a promising Victorian gold portfolio, supported by plans for a $1.5 million equity raise.

Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.

Bryah Resources has secured the Golden Pike gold and antimony project in Canada, appointed Greg Hill as CEO, and raised nearly $2 million to fund upcoming drilling and resource upgrades.

Felix Gold Limited has made significant strides in transitioning its Treasure Creek project from exploration to operational readiness, positioning itself as a key domestic supplier of critical antimony for the U.S. market.